ArticleNPJ digital medicine2025
Multi-domain rule-based phenotyping algorithms enable improved GWAS signal.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Maternal sleep deprivation reshapes offspring hippocampal development through a Trem2-centered microglial program revealed by single-nucleus and spatial transcriptomics.Molecular psychiatry · 2026Article
- Genetic Evidence for Unified Airway Disease: Shared Epithelial and Immune Architecture Across Major Airway Diseases.International journal of molecular sciences · 2026Article
- Robust replication of associations across patient-mediated and provider-sourced EHR data in thenpj digital public health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Biobanks are a rich source of data for genome-wide association studies (GWAS). They store clinical data from electronic health records, with data domains such as laboratory measurements, conditions, and self-reported diagnoses. Traditionally, biobank GWAS utilize case-control cohorts built exclusively from conditions. However, because reported conditions are primarily collected for billing purposes, they face data quality issues. Consequently, incorporating additional data domains in cohort construction can improve cohort accuracy and GWAS results. Here, we assess the impact of various rule-based phenotyping algorithms on GWAS outcomes, examining factors such as power, heritability, replicability, functional annotations, and polygenic risk score prediction accuracy across seven diseases in the UK Biobank. We find that high complexity phenotyping algorithms generally improve GWAS outcomes, including increased power, hits within coding and functional genomic regions, and co-localization with expression quantitative trait loci. Our findings suggest that biobank-scale GWAS can benefit from phenotyping algorithms that integrate multiple data domains.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.